Remove Generic Drugs Remove Medicine Remove Pharmacy
article thumbnail

Pharmacognosy and Drug Patents: Unveiling Nature’s Medicinal Treasures

Drug Patent Watch

This intersection is where pharmacognosy meets drug patents, creating a unique landscape that shapes the future of medicine. But what exactly is pharmacognosy, and how does it relate to the complex world of drug patents? They then isolate and identify compounds with potential medicinal properties.

article thumbnail

The Role of Scientific Expertise in Generic Drug Development

Drug Patent Watch

Generic drug development is a complex process that involves not only scientific and medical expertise but also adherence to strict legal and ethical standards. Scientific expertise plays a crucial role in ensuring that generic drugs are held to the same standards of quality, safety, and efficacy as their brand-name counterparts.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Eli Lilly Partners with Amazon Pharmacy for Home Delivery of Drugs

XTalks

LillyDirect Pharmacy Solutions, Eli Lilly’s direct-to-consumer (DTC) drugs website, is teaming up with Amazon Pharmacy to deliver select medications to people’s homes. Physicians can send prescriptions for their patients either to LillyDirect Pharmacy Solutions or Amazon Pharmacy.

Pharmacy 111
article thumbnail

Disruption in healthcare is coming

World of DTC Marketing

Then there is the cost of generic drugs. Mark Cuban made a big splash in the world of gener­ic medications when he launched a new com­pa­ny ear­li­er this year, pledg­ing to on­ly charge a 15% mark-up for its gener­ic medicines, Wide­spread cost sav­ings from us­ing Cuban’s new com­pa­ny could be steep.

Pharmacy 227
article thumbnail

STAT+: Civica Rx begins selling its first generic drug as it tries to overhaul the pharmaceutical supply chain

STAT News

In the latest bid to address high prescription drug costs, a nonprofit plans to sell a cheaper generic version of an expensive cancer medicine in the U.S.

article thumbnail

PBMs and insurers want your prescription money

World of DTC Marketing

anti-kickback law that the drugmaker said prevented it from helping heart failure patients, many with low incomes, afford the medicine that costs $225,000 annually. A drug’s out-of-pocket cost is primarily the result of decisions made by insurance companies and pharmacy benefit managers (PBMs).

Pharmacy 226
article thumbnail

Do generics producers have what it takes to tackle complex and specialty drugs?

Pharmaceutical Technology

The only way forward for generics producers. Margins in the generics market are overall being driven down, Harvard Medical School Health Economics professor Richard Frank, PhD, tells Pharmaceutical Technology. They are sometimes referred to as hybrid medicines by the European Medicines Agency (EMA).

Drugs 298